AU2001263105A1 - Human semaphorin homologs and polynucleotides encoding the same - Google Patents
Human semaphorin homologs and polynucleotides encoding the sameInfo
- Publication number
- AU2001263105A1 AU2001263105A1 AU2001263105A AU6310501A AU2001263105A1 AU 2001263105 A1 AU2001263105 A1 AU 2001263105A1 AU 2001263105 A AU2001263105 A AU 2001263105A AU 6310501 A AU6310501 A AU 6310501A AU 2001263105 A1 AU2001263105 A1 AU 2001263105A1
- Authority
- AU
- Australia
- Prior art keywords
- homologs
- same
- polynucleotides encoding
- human semaphorin
- semaphorin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000014105 Semaphorin Human genes 0.000 title 1
- 108050003978 Semaphorin Proteins 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20527400P | 2000-05-18 | 2000-05-18 | |
| US60/205,274 | 2000-05-18 | ||
| US20889300P | 2000-06-02 | 2000-06-02 | |
| US60/208,893 | 2000-06-02 | ||
| PCT/US2001/015489 WO2001088133A2 (en) | 2000-05-18 | 2001-05-14 | Human semaphorin homologs and polynucleotides encoding the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001263105A1 true AU2001263105A1 (en) | 2001-11-26 |
Family
ID=26900266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001263105A Abandoned AU2001263105A1 (en) | 2000-05-18 | 2001-05-14 | Human semaphorin homologs and polynucleotides encoding the same |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US6750054B2 (en) |
| AU (1) | AU2001263105A1 (en) |
| WO (1) | WO2001088133A2 (en) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030138899A1 (en) * | 1999-05-25 | 2003-07-24 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20080213878A1 (en) * | 1999-10-19 | 2008-09-04 | Gregory Donoho | Novel human membrane proteins and polynucleotides encoding the same |
| US20030119133A1 (en) * | 2001-01-16 | 2003-06-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2003101400A2 (en) * | 2002-06-04 | 2003-12-11 | Avalon Pharmaceuticals, Inc. | Cancer-linked gene as target for chemotherapy |
| US20050276812A1 (en) | 2004-06-01 | 2005-12-15 | Genentech, Inc. | Antibody-drug conjugates and methods |
| PT2489364E (en) | 2003-11-06 | 2015-04-16 | Seattle Genetics Inc | Monomethylvaline compounds conjugated to antibodies |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| NZ553500A (en) | 2004-09-23 | 2009-11-27 | Genentech Inc Genentech Inc | Cysteine engineered antibodies and conjugates withCysteine engineered antibodies and conjugates with a free cysteine amino acid in the heavy chain a free cysteine amino acid in the heavy chain |
| CA2809819A1 (en) | 2009-09-09 | 2011-03-17 | Centrose, Llc | Extracellular targeted drug conjugates |
| MA34277B1 (en) | 2010-04-15 | 2013-06-01 | Spirogen Developments Sarl | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |
| US9000130B2 (en) | 2010-06-08 | 2015-04-07 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| CN103313990B (en) | 2010-11-17 | 2016-07-20 | 基因泰克公司 | Alanyl maytansinol antibody coupling matter |
| ES2567276T3 (en) | 2011-05-12 | 2016-04-21 | Genentech, Inc. | LC-MS / MS method of monitoring multiple reactions to detect therapeutic antibodies in animal samples using frame-changing peptides |
| DK2750713T3 (en) | 2011-10-14 | 2015-12-21 | Medimmune Ltd | PYRROLOBENZODIAZEPINS AND CONJUGATES THEREOF |
| WO2013130093A1 (en) | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
| US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| KR101995621B1 (en) | 2012-10-12 | 2019-07-03 | 에이디씨 테라퓨틱스 에스에이 | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| US9931414B2 (en) | 2012-10-12 | 2018-04-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| JP6270859B2 (en) | 2012-10-12 | 2018-01-31 | エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ | Pyrrolobenzodiazepine-antibody conjugate |
| JP5993093B2 (en) | 2012-10-12 | 2016-09-14 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | Pyrrolobenzodiazepines and their complexes |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| EP2906296B1 (en) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| HK1216176A1 (en) | 2012-12-21 | 2016-10-21 | Medlmmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
| AU2013366493B2 (en) | 2012-12-21 | 2017-08-24 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| AU2014230735B2 (en) | 2013-03-13 | 2018-03-15 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| AU2014229529B2 (en) | 2013-03-13 | 2018-02-15 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| WO2014159981A2 (en) | 2013-03-13 | 2014-10-02 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US10442836B2 (en) | 2013-08-12 | 2019-10-15 | Genentech, Inc. | 1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
| EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US10010624B2 (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US9956299B2 (en) | 2013-10-11 | 2018-05-01 | Medimmune Limited | Pyrrolobenzodiazepine—antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| WO2015095223A2 (en) | 2013-12-16 | 2015-06-25 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
| BR112016013861A2 (en) | 2013-12-16 | 2017-10-10 | Genentech Inc | drug and antibody conjugates, compounds, treatment method and pharmaceutical composition |
| BR112016013258A2 (en) | 2013-12-16 | 2018-01-16 | Genentech Inc | antibody-drug conjugate, pharmaceutical composition, method for treating cancer and kit |
| CN106687141A (en) | 2014-09-10 | 2017-05-17 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines and conjugates thereof |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| MX2017003123A (en) | 2014-09-12 | 2017-05-12 | Genentech Inc | Cysteine engineered antibodies and conjugates. |
| WO2016040825A1 (en) | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anthracycline disulfide intermediates, antibody-drug conjugates and methods |
| SG11201702079UA (en) | 2014-09-17 | 2017-04-27 | Genentech Inc | Pyrrolobenzodiazepines and antibody disulfide conjugates thereof |
| BR112017011111A2 (en) | 2014-11-25 | 2017-12-26 | Adc Therapeutics Sa | pyrrolobenzodiazepine-antibody conjugates |
| EP3226909A1 (en) | 2014-12-03 | 2017-10-11 | Genentech, Inc. | Quaternary amine compounds and antibody-drug conjugates thereof |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| MA43345A (en) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| MA43354A (en) | 2015-10-16 | 2018-08-22 | Genentech Inc | CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE |
| MA45326A (en) | 2015-10-20 | 2018-08-29 | Genentech Inc | CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| CN121431692A (en) | 2016-03-25 | 2026-01-30 | 豪夫迈·罗氏有限公司 | Multiplex total antibodies and antibody conjugated drug quantification assays |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| JP2019522633A (en) | 2016-05-20 | 2019-08-15 | ジェネンテック， インコーポレイテッド | PROTAC antibody conjugates and methods of use |
| JP7022080B2 (en) | 2016-05-27 | 2022-02-17 | ジェネンテック， インコーポレイテッド | Biochemical analytical methods for the characterization of site-specific antibody-drug conjugates |
| EP3464280B1 (en) | 2016-06-06 | 2021-10-06 | F. Hoffmann-La Roche AG | Silvestrol antibody-drug conjugates and methods of use |
| JP7093767B2 (en) | 2016-08-11 | 2022-06-30 | ジェネンテック， インコーポレイテッド | Pyrrolobenzodiazepine prodrug and its antibody conjugate |
| JP7050770B2 (en) | 2016-10-05 | 2022-04-08 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Method for preparing antibody drug conjugate |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| HUE054689T2 (en) | 2017-02-08 | 2021-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine antibody conjugates |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| SI3612537T1 (en) | 2017-04-18 | 2022-10-28 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
| EP3612234B1 (en) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Combination therapy with an anti-axl antibody-drug conjugate |
| CA3064804A1 (en) | 2017-06-14 | 2018-12-20 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc |
| SG11202000358YA (en) | 2017-08-18 | 2020-02-27 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| IL273387B2 (en) | 2017-09-20 | 2023-10-01 | Ph Pharma Co Ltd | Thailanstatin analogs |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
| AU2019365238A1 (en) | 2018-10-24 | 2021-05-13 | F. Hoffmann-La Roche Ag | Conjugated chemical inducers of degradation and methods of use |
| JP2022513198A (en) | 2018-12-10 | 2022-02-07 | ジェネンテック， インコーポレイテッド | Photocrosslinkable peptide for site-specific conjugation to Fc-containing proteins |
| GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
| MX2021010477A (en) | 2019-03-15 | 2021-10-01 | Medimmune Ltd | Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer. |
| GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
| AU2021362997A1 (en) | 2021-11-03 | 2024-05-16 | Hangzhou Dac Biotech Co., Ltd. | Specific conjugation of an antibody |
| WO2024138128A2 (en) | 2022-12-23 | 2024-06-27 | Genentech, Inc. | Cereblon degrader conjugates, and uses thereof |
| CN121263210A (en) | 2023-04-17 | 2026-01-02 | 沛科生物公司 | Antibodies and antibody-drug conjugates, as well as their usage, synthesis processes, and intermediates |
| WO2026006689A2 (en) | 2024-06-28 | 2026-01-02 | Firefly Bio, Inc. | Bcl-xl degrader antibody conjugates and uses thereof |
| WO2026006688A2 (en) | 2024-06-28 | 2026-01-02 | Firefly Bio, Inc. | Degrader antibody conjugates and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4215051A (en) | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| DE3301833A1 (en) | 1983-01-20 | 1984-07-26 | Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig | METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL OLIGONOCLEOTIDES IN A SOLID PHASE |
| US4713326A (en) | 1983-07-05 | 1987-12-15 | Molecular Diagnostics, Inc. | Coupling of nucleic acids to solid support by photochemical methods |
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5639856A (en) * | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| AU3003395A (en) | 1994-07-15 | 1996-02-16 | Cephalon, Inc. | Active calpain expressed by baculovirus |
| US5908635A (en) | 1994-08-05 | 1999-06-01 | The United States Of America As Represented By The Department Of Health And Human Services | Method for the liposomal delivery of nucleic acids |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US5948767A (en) | 1994-12-09 | 1999-09-07 | Genzyme Corporation | Cationic amphiphile/DNA complexes |
| US5494595A (en) | 1994-12-30 | 1996-02-27 | Huntsman Corporation | Oil soluble polyethers |
| US5558752A (en) * | 1995-04-28 | 1996-09-24 | General Motors Corporation | Exhaust gas sensor diagnostic |
| US5654173A (en) | 1996-08-23 | 1997-08-05 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| JP2002537757A (en) | 1998-08-24 | 2002-11-12 | アルファジーン・インコーポレイテッド | Secreted proteins and polynucleotides encoding them |
| AU1450101A (en) * | 1999-11-02 | 2001-05-14 | Zymogenetics Inc. | Human semaphorin |
-
2001
- 2001-05-14 AU AU2001263105A patent/AU2001263105A1/en not_active Abandoned
- 2001-05-14 US US09/854,845 patent/US6750054B2/en not_active Expired - Fee Related
- 2001-05-14 WO PCT/US2001/015489 patent/WO2001088133A2/en not_active Ceased
-
2004
- 2004-04-28 US US10/833,509 patent/US7199221B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050054040A1 (en) | 2005-03-10 |
| WO2001088133A2 (en) | 2001-11-22 |
| US6750054B2 (en) | 2004-06-15 |
| US20020098491A1 (en) | 2002-07-25 |
| WO2001088133A3 (en) | 2003-05-08 |
| US7199221B2 (en) | 2007-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001263105A1 (en) | Human semaphorin homologs and polynucleotides encoding the same | |
| AU2002252705A1 (en) | Polynucleotides and polypeptides associated with the nf-kb pathway | |
| AU2001265009A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
| AU2001280608A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
| AU2002227925A1 (en) | Human beta-defensin-3 | |
| AU2001240075A1 (en) | Full length expressed polynucleotides and the polypeptides they encode | |
| AU2092901A (en) | Polynucleotides encoding human protease homologs | |
| AU2001235003A1 (en) | Novel human lysozymes and polynucleotides encoding the same | |
| AU2002246858A1 (en) | Human kinases and polynucleotides encoding the same | |
| AU2002213183A1 (en) | Human kinases and polynucleotides encoding the same | |
| AU2002318186A1 (en) | Novel human kielin-like proteins and polynucleotides encoding the same | |
| AU2001241446A1 (en) | Human transporter proteins and polynucleotides encoding the same | |
| AU2001285326A1 (en) | Human kinase proteins and polynucleotides encoding the same | |
| AU2001238503A1 (en) | Novel human thrombospondin repeat proteins and polynucleotides encoding the same | |
| AU3264202A (en) | Novel human kinases and polynucleotides encoding the same | |
| AU2001266844A1 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same | |
| AU2002215312A1 (en) | Human proteases and polynucleotides encoding the same | |
| AU2001275337A1 (en) | Novel human transporter proteins and polynucleotides encoding the same | |
| AU7044101A (en) | A novel polypeptide, a human methylthioadenosine phosphorylase 37 and the polynucleotide encoding the polypeptide | |
| AU2001274923A1 (en) | Novel human thrombospondin-like proteins and polynucleotides encoding the same | |
| AU7101700A (en) | Human calcium dependent proteases and polynucleotides encoding the same | |
| AU2002233265A1 (en) | Human caplain proteins and polynucleotides coding therefor | |
| AU1134702A (en) | Novel human proteases and polynucleotides encoding the same | |
| AU2002228633A1 (en) | Human kinases and polynucleotides encoding the same | |
| AU4726901A (en) | Novel human proteins and polynucleotides encoding the same |